Evidence map›Paper›PMID 23247122›Full record

ArticleShock (Augusta, Ga.)2013

Plasma bacterial and mitochondrial DNA distinguish bacterial sepsis from sterile systemic inflammatory response syndrome and quantify inflammatory tissue injury in nonhuman primates.

Tolga Sursal, Deborah J Stearns-Kurosawa, Kiyoshi Itagaki, Sun-Young Oh, Shiqin Sun, Shinichiro Kurosawa, Carl J Hauser

Open access · greenAbstract read
In one paragraph

Article in Shock (Augusta, Ga.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 91 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Decreasing mRNA HMGB1 expression inAnnals of medicine and surgery (2012) · 2023
    Article
  7. Can Neutrophils Prevent Nosocomial Pneumonia after Serious Injury?International journal of molecular sciences · 2023
    Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Prognostic Power of Pathogen Cell-Free DNA inOpen forum infectious diseases · 2019
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Tolga SursalDepartment of Surgery, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Deborah J Stearns-Kurosawa
Kiyoshi Itagaki
Sun-Young Oh
Shiqin Sun
Shinichiro Kurosawa
Carl J Hauser
Hadassah Medical Center · IL

Funding

Translation of immunologic technologies from basic research into pre-clinical nonU19AI062629 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI THOMPSON, LINDA F · 2004 to 2023
$56.2M
SHIGA-TOXINS: PRE-CLINICAL ANIMAL MODEL DEVELOPMENT AND THERAPEUTIC TESTINGU01AI075386 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI KUROSAWA, SHINICHIRO · 2007 to 2011
$3.7M
PRIMATE MODEL AND PATHOGENESIS OF ANTHRAX SEPSISR01AI058107 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI KUROSAWA, SHINICHIRO · 2005 to 2009
$2.4M
Mitochondrial DAMPs and Inflammation after injuryR01GM089711 · NIGMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI HAUSER, CARL J · 2010 to 2013
$1.7M
NIAID NIH HHS R01 AI058107NIAID NIH HHS U01 AI075386NIAID NIH HHS U19 AI062629NIAID NIH HHS UO1 AI1075386NIGMS NIH HHS R01 GM089711
6 · The paper itself

Abstract

Systemic inflammatory response syndrome (SIRS) is a fundamental host response common to bacterial infection and sterile tissue injury. Systemic inflammatory response syndrome can cause organ dysfunction and death, but its mechanisms are incompletely understood. Moreover, SIRS can progress to organ failure or death despite being sterile or after control of the inciting infection. Biomarkers discriminating between sepsis, sterile SIRS, and postinfective SIRS would therefore help direct care. Circulating mitochondrial DNA (mtDNA) is a damage-associated molecular pattern reflecting cellular injury. Circulating bacterial 16S DNA (bDNA) is a pathogen-associated pattern (PAMP) reflecting ongoing infection. We developed quantitative polymerase chain reaction assays to quantify these markers, and predicting their plasma levels might help distinguish sterile injury from infection. To study these events in primates, we assayed banked serum from Papio baboons that had undergone a brief challenge of intravenous Bacillus anthracis delta Sterne (modified to remove toxins) followed by antibiotics (anthrax) that causes organ failure and death. To investigate the progression of sepsis to "severe" sepsis and death, we studied animals where anthrax was pretreated with drotrecogin alfa (activated protein C), which attenuates sepsis in baboons. We also contrasted lethal anthrax bacteremia against nonlethal E. coli bacteremia and against sterile tissue injury from Shiga-like toxin 1. Bacterial DNA and mtDNA levels in timed samples were correlated with blood culture results and assays of organ function. Sterile injury by Shiga-like toxin 1 increased mtDNA, but bDNA was undetectable: consistent with the absence of infection. The bacterial challenges caused parallel early bDNA and mtDNA increases, but bDNA detected pathogens even after bacteria were undetectable by culture. Sublethal E. coli challenge only caused transient rises in mtDNA consistent with a self-limited injury. In lethal anthrax challenge (n = 4), bDNA increased transiently, but mtDNA levels remained elevated until death, consistent with persistent septic tissue damage after bacterial clearance. Critically, activated protein C pretreatment (n = 4) allowed mtDNA levels to decay after bacterial clearance with sparing of organ function and survival. In summary, host tissue injury correlates with mtDNA whether infective or sterile. Mitochondrial DNA and bDNA polymerase chain reactions can quantify tissue injury incurred by septic or sterile mechanisms and suggest the source of SIRS of unknown origin.

Indexed as

AnimalsAnthraxAnti-Bacterial AgentsBacteremiaBiomarkersDiagnosis, DifferentialDisease ProgressionDisseminated Intravascular CoagulationDNA, BacterialDNA, MitochondrialEscherichia coli InfectionsMultiple Organ FailurePapioProtein CRecombinant ProteinsSurvival AnalysisAnti-Bacterial AgentsBiomarkersDNA, BacterialDNA, Mitochondrialdrotrecogin alfa activatedProtein CRecombinant Proteins

Identifiers

PMID23247122
PMCPMC3537509
OpenAlexW2037967873

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.